Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Bimzelx“
Suchtreffer
Begriffe & Kennungen
Bimzelx
Eintrag öffnenBimzelx · 4.1 Therapeutic indications · 1
Eintrag öffnenBimzelx · 4.3 Contraindications · 1
Eintrag öffnenBimzelx · 4.3 · Clinically important active infections (e.g. active tuberculosis, see section 4.4).
Eintrag öffnenBimzelx · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenBimzelx · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenBimzelx · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenBimzelx · 4.5 · Live vaccines should not be given concurrently with bimekizumab (see section 4.4).
Eintrag öffnenBimzelx · 4.5 · No interaction studies have been performed. There is no direct evidence for the role of IL-17A or IL-17F in th
Eintrag öffnenBimzelx · 4.5 · Population pharmacokinetic (PK) data analyses indicated that concomitant administration of conventional diseas
Eintrag öffnenBimzelx · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenBimzelx · 4.8 Undesirable effects · 1
Eintrag öffnenBimzelx · 4.8 · 8 Hidradenitis suppurativa
Eintrag öffnenBimzelx · 4.8 · A total of 5862 patients have been treated with bimekizumab in blinded and open-label clinical studies in plaq
Eintrag öffnenBimzelx · 4.8 · Across indications, no clinically meaningful impact on clinical response was associated with anti- bimekizumab
Eintrag öffnenBimzelx · 4.8 · Adverse reactions from clinical studies and post-marketing reports (Table 1) are classified by MedDRA System O
Eintrag öffnenBimzelx · 4.8 · Approximately 31% of patients with psoriatic arthritis treated with bimekizumab at the recommended dosing regi
Eintrag öffnenBimzelx · 4.8 · Approximately 44% of patients with AS treated with bimekizumab up to 52 weeks at the recommended dosing regime
Eintrag öffnenBimzelx · 4.8 · Approximately 45% of plaque psoriasis patients treated with bimekizumab up to 56 weeks at the recommended dosi
Eintrag öffnenBimzelx · 4.8 · Approximately 57% of patients with nr-axSpA treated with bimekizumab up to 52 weeks at the recommended dosing
Eintrag öffnen